Among older adults and adults with low atherosclerotic cardiovascular disease risk, use of aspirin decreased after 2019.
Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent ...